Prognostic value of radiological response to chemotherapy in patients with osteosarcoma.
<h4>Background</h4>Chemotherapy is essential to improve the prognosis of the patients with osteosarcoma, and the response to chemotherapy is an important prognostic factor. In this study, the impact of various radiological examinations on overall survival (OS) and event-free survival (EF...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/348e6e348ffd4ee9a8f6020f34cc2df9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:348e6e348ffd4ee9a8f6020f34cc2df9 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:348e6e348ffd4ee9a8f6020f34cc2df92021-11-18T09:02:20ZPrognostic value of radiological response to chemotherapy in patients with osteosarcoma.1932-620310.1371/journal.pone.0070015https://doaj.org/article/348e6e348ffd4ee9a8f6020f34cc2df92013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23922892/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Chemotherapy is essential to improve the prognosis of the patients with osteosarcoma, and the response to chemotherapy is an important prognostic factor. In this study, the impact of various radiological examinations on overall survival (OS) and event-free survival (EFS) was evaluated.<h4>Method</h4>Eighty-two patients with high-grade osteosarcoma were included in this study, and we evaluated the following factors for prognostic significance: age (≥40 years), gender (male), tumor location (truncal site), metastatic disease, histological response to chemotherapy, radiological response to chemotherapy assessed using X-ray, angiography, CT, MRI, (201)Tl scintigraphy, and (99m)Tc-MIBI scintigraphy ((99m)Tc-MIBI), and combined radiological score (CRS).<h4>Results</h4>Univariate analyses revealed that metastatic disease, histological response, (99m)Tc-MIBI, and CRS were significantly correlated with OS. Multivariate analyses showed that metastatic disease (OS: HR 35.9, P<0.001; EFS: HR 17.32, P<0.001) was an independent predictor of OS and EFS. Tumor location (HR 36.1, P = 0.003), histological response (HR 31.1, P = 0.036), and (99m)Tc-MIBI (HR 18.4, P = 0.038) were significant prognostic factors for OS. Moreover, CRS was a marginally significant predictor of OS and EFS.<h4>Conclusion</h4>The chemotherapeutic effects evaluated by (99m)Tc-MIBI and CRS could be considered as prognostic factors in osteosarcoma.Shinji MiwaAkihiko TakeuchiToshiharu ShiraiJunichi TakiNorio YamamotoHideji NishidaKatsuhiro HayashiYoshikazu TanzawaHiroaki KimuraKentaro IgarashiAkishi OoiHiroyuki TsuchiyaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 7, p e70015 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Shinji Miwa Akihiko Takeuchi Toshiharu Shirai Junichi Taki Norio Yamamoto Hideji Nishida Katsuhiro Hayashi Yoshikazu Tanzawa Hiroaki Kimura Kentaro Igarashi Akishi Ooi Hiroyuki Tsuchiya Prognostic value of radiological response to chemotherapy in patients with osteosarcoma. |
description |
<h4>Background</h4>Chemotherapy is essential to improve the prognosis of the patients with osteosarcoma, and the response to chemotherapy is an important prognostic factor. In this study, the impact of various radiological examinations on overall survival (OS) and event-free survival (EFS) was evaluated.<h4>Method</h4>Eighty-two patients with high-grade osteosarcoma were included in this study, and we evaluated the following factors for prognostic significance: age (≥40 years), gender (male), tumor location (truncal site), metastatic disease, histological response to chemotherapy, radiological response to chemotherapy assessed using X-ray, angiography, CT, MRI, (201)Tl scintigraphy, and (99m)Tc-MIBI scintigraphy ((99m)Tc-MIBI), and combined radiological score (CRS).<h4>Results</h4>Univariate analyses revealed that metastatic disease, histological response, (99m)Tc-MIBI, and CRS were significantly correlated with OS. Multivariate analyses showed that metastatic disease (OS: HR 35.9, P<0.001; EFS: HR 17.32, P<0.001) was an independent predictor of OS and EFS. Tumor location (HR 36.1, P = 0.003), histological response (HR 31.1, P = 0.036), and (99m)Tc-MIBI (HR 18.4, P = 0.038) were significant prognostic factors for OS. Moreover, CRS was a marginally significant predictor of OS and EFS.<h4>Conclusion</h4>The chemotherapeutic effects evaluated by (99m)Tc-MIBI and CRS could be considered as prognostic factors in osteosarcoma. |
format |
article |
author |
Shinji Miwa Akihiko Takeuchi Toshiharu Shirai Junichi Taki Norio Yamamoto Hideji Nishida Katsuhiro Hayashi Yoshikazu Tanzawa Hiroaki Kimura Kentaro Igarashi Akishi Ooi Hiroyuki Tsuchiya |
author_facet |
Shinji Miwa Akihiko Takeuchi Toshiharu Shirai Junichi Taki Norio Yamamoto Hideji Nishida Katsuhiro Hayashi Yoshikazu Tanzawa Hiroaki Kimura Kentaro Igarashi Akishi Ooi Hiroyuki Tsuchiya |
author_sort |
Shinji Miwa |
title |
Prognostic value of radiological response to chemotherapy in patients with osteosarcoma. |
title_short |
Prognostic value of radiological response to chemotherapy in patients with osteosarcoma. |
title_full |
Prognostic value of radiological response to chemotherapy in patients with osteosarcoma. |
title_fullStr |
Prognostic value of radiological response to chemotherapy in patients with osteosarcoma. |
title_full_unstemmed |
Prognostic value of radiological response to chemotherapy in patients with osteosarcoma. |
title_sort |
prognostic value of radiological response to chemotherapy in patients with osteosarcoma. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2013 |
url |
https://doaj.org/article/348e6e348ffd4ee9a8f6020f34cc2df9 |
work_keys_str_mv |
AT shinjimiwa prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma AT akihikotakeuchi prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma AT toshiharushirai prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma AT junichitaki prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma AT norioyamamoto prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma AT hidejinishida prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma AT katsuhirohayashi prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma AT yoshikazutanzawa prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma AT hiroakikimura prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma AT kentaroigarashi prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma AT akishiooi prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma AT hiroyukitsuchiya prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma |
_version_ |
1718421014923182080 |